| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/01/2006 | WO2005095395A3 Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors |
| 06/01/2006 | WO2005089094A3 Materials and methods for the preparation of anisotropically-ordered solids |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant |
| 06/01/2006 | US20060116395 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116376 Therapy of central nervous disorders and conditions including attention deficit hyperactivity disorder, neuropathic pain, urinary incontinence, anxiety, depression, and schizophrenia and fibromyalgia |
| 06/01/2006 | US20060116363 Tricyclic derivatives as ltd4 antagonists |
| 06/01/2006 | US20060116356 Phosphonate analogs of HIV integrase inhibitor compounds |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060113968 Novel benzonaphthyridines |
| 06/01/2006 | US20060113530 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 06/01/2006 | DE102004057585A1 New rylene tetracarbonic acid diimide compounds useful e.g. for coloring high-molecular organic and inorganic materials; as dispersants; preparing aqueous polymer dispersions, markings and letters that absorb light from infra-red light |
| 06/01/2006 | DE102004056820A1 Preparation of dihydroindene derivatives comprises reacting benzene compounds with indene compounds in the presence of catalyst system containing e.g. ligand and a solvent system containing two solvents from e.g. tertiary amine and alcohol |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2589438A1 Treatment of inflammatory bowel disease |
| 06/01/2006 | CA2588812A1 Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
| 06/01/2006 | CA2587256A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/31/2006 | EP1660497A1 [ 1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 05/31/2006 | EP1660496A1 Process for the synthesis of zolpidem |
| 05/31/2006 | EP1660495A1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 05/31/2006 | EP1660489A1 Intermediate products for producing oxazolidinone-quinolone hybrids |
| 05/31/2006 | EP1660484A1 Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660461A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660444A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660092A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0839040B1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 05/31/2006 | CN1780839A Novel intermediate for the preparation of therapeutically active imidazopyridines |
| 05/31/2006 | CN1780838A Azabicyclononene derivatives |
| 05/31/2006 | CN1780837A Azabicyclononene derivatives |
| 05/31/2006 | CN1780836A Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| 05/31/2006 | CN1780835A Novel fused heterocycles and uses thereof. |
| 05/31/2006 | CN1780834A Imidazopyridine intermediates |
| 05/31/2006 | CN1780831A 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 05/31/2006 | CN1780625A Isoquinoline derivatives and methods of use thereof |
| 05/31/2006 | CN1780624A Tetracyclic benzamide derivatives and methods of use thereof |
| 05/31/2006 | CN1778801A Quinolone7-((4-((Z)-2-(2-amino-4-thiazyl)-2- methoxy imino acetyl)-1-piperazine) compound |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/30/2006 | US7053219 such as 5-methyl-6-(4-methoxyphenyl)-3-pyridin-4-yl-isoxazolo[4,5-c]pyridin-4(5H)one which has metabotropic glutamic acid receptor-antagonistic effect; for treatment of anxiety disorders, psychosomatic disorders, and eating disorders |
| 05/30/2006 | US7053218 stirring with excess of aluminum chloride and sulfuric acid |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053210 Efficient synthesis of pyropheophorbide a and its derivatives |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053102 A beta -hydroxylactone replaces the natural alpha -hydroxylactone of camptothecin; for treating colon and breast cancer |
| 05/30/2006 | US7053101 Orphan opioid receptor (orl-1) ligands; anxiety, depression, neuropathic and acute pain, migraines, asthma, improved cognition |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053070 Antiproliferative agents; anticarcinogenic agents; viricides |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2282406C Catalysts and methods for catalytic oxidation |
| 05/30/2006 | CA2267103C Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055752A2 INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006053784A2 1,7-naphthyridines as pde4 inhibitors |
| 05/26/2006 | WO2006029153A3 Monocyclic anilide spirolactam cgrp receptor antagonists |
| 05/26/2006 | WO2006026760A3 1-amino imidazo-containing compounds and methods |
| 05/26/2006 | WO2006004636A3 Fused heterocyclic kinase inhibitors |
| 05/26/2006 | WO2005123080A3 Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| 05/26/2006 | CA2587153A1 Inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111392 Substituted biaryl-carboxylate derivatives |
| 05/25/2006 | US20060111391 6-(3-nitro-phenyl)-3,3-spiro[cyclohexane]-imidazo[1,2-a]pyridin-2-one; depletion of estrogen, osteopenia, osteoporosis; hormone sensitive cancers, hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111387 Immonomoderators; viricides; anticancer agents; for example, 2-Butyl-1-isobutyl-7-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-4-amine; use of these compounds for inducing or inhibiting cytokine biosynthesis in animals |
| 05/25/2006 | US20060111380 4-(2-naphtyl)-2-[3-oxospiro[isobenzofuran-1 (3H), 4'-piperidin]-1'-yl]-1H-imidazole, 4-(4-bromophenyl)-2-[3-oxospiro[isobenzofuran-1(3H),4'-piperidin]-1-yl]-1H imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111337 Substituted biaryl quinolin-4-ylamine analogues |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/25/2006 | US20060110433 Adhesive patch |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |